Increase or decrease in nasal airway resistance induced by acetylcholine in anesthetized dogs: vascular mechanisms.

M A Lung; J C Wang

doi:10.1177/000348949410300812

Home/Archive/PubMed

PubMed · 8060060

Increase or decrease in nasal airway resistance induced by acetylcholine in anesthetized dogs: vascular mechanisms.

M A Lung·J C Wang

View original source ↗Export metadata ↓

Abstract

In sodium pentobarbital-anesthetized dogs with spontaneous nasal blood flow or constant-flow vascular perfusion of the nasal mucosa, we measured nasal airway resistance, vascular resistance, and arterial inflow and outflow of the anterior and posterior venous systems. Acetylcholine in low doses (< 5 micrograms/kg per minute, intraarterially) increased nasal airway resistance, and the response was greater in dogs with spontaneous blood flow. Nasal vascular resistance was decreased. However, the posterior venous outflow was increased and the anterior venous outflow was decreased in dogs with constant-flow vascular perfusion. Acetylcholine in higher doses (> 5 micrograms/kg per minute, intraarterially) decreased nasal airway resistance, and vascular resistance fell further, but both venous outflows were increased in dogs with spontaneous blood flow or constant-flow vascular perfusion. The results indicate that acetylcholine may increase or decrease nasal airway resistance, depending on the dose administered, probably via a dose-dependent differential action on different components of the nasal vascular bed.

Explore related subjects

Acetylcholine Airway Resistance Anesthesia, Intravenous Animals Dogs Dose-Response Relationship, Drug Female Male Nasal Mucosa Regional Blood Flow Vascular Resistance Vasodilation Journal Article Research Support, Non-U.S. Gov't

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

M A Lung, J C Wang. 1994. Increase or decrease in nasal airway resistance induced by acetylcholine in anesthetized dogs: vascular mechanisms.. https://doi.org/10.1177/000348949410300812

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1997

Slow-channel myasthenic syndrome caused by enhanced activation, desensitization, and agonist binding affinity attributable to mutation in the M2 domain of the acetylcholine receptor alpha subunit.

We describe a novel genetic and kinetic defect in a slow-channel congenital myasthenic syndrome. The severely disabled propositus has advanced endplate myopathy, prolonged and biexponentially decaying endplate currents, and prolonged acetylcholine receptor (AChR) channel openings. Genetic analysis reveals the heterozygous mutation alphaV249F in the propositus and mosaicism for alphaV249F in the asymptomatic father. Unlike mutations described previously in the M2 transmembrane domain, alphaV249F is located N-terminal to the conserved leucines and is not predicted to face the channel lumen. Expression of the alphaV249F AChR in HEK fibroblasts demonstrates increased channel openings in the absence of ACh, prolonged openings in its presence, enhanced steady-state desensitization, and nanomolar rather than micromolar affinity of one of the two binding sites in the resting activatable state. Thus, neuromuscular transmission is compromised because cationic overloading leads to degenerating junctional folds and loss of AChR, because an increased fraction of AChR is desensitized in the resting state, and because physiological rates of stimulation elicit additional desensitization and depolarization block of transmission.

Acetylcholine↗

PubMed1997

Quantal neurotransmitter secretion rate exhibits fractal behavior.

The rate of exocytic events from both neurons and non-neuronal cells exhibits fluctuations consistent with fractal (self-similar) behavior in time, as evidenced by a number of statistical measures. We explicitly demonstrate this for neurotransmitter secretion at Xenopus neuromuscular junctions and for rat hippocampal synapses in culture; the exocytosis of exogenously supplied neurotransmitter from cultured Xenopus myocytes and from rat fibroblasts behaves similarly. The magnitude of the fluctuations of the rate of exocytic events about the mean decreases slowly as the rate is computed over longer and longer time periods, the periodogram decreases in power-law manner with frequency, and the Allan factor (relative variance of the number of exocytic events) increases as a power-law function of the counting time. These features are hallmarks of self-similar behavior. Their description requires models that exhibit long-range correlation (memory) in event occurrences. We have developed a physiologically plausible model that accords with all of the statistical measures that we have examined. The appearance of fractal behavior at synapses, as well as in systems comprising collections of synapses, indicates that such behavior is ubiquitous in neural signaling.

Acetylcholine↗

PubMed1997

Identification of an 8-lipoxygenase pathway in nervous tissue of Aplysia californica.

Arachidonic acid is converted to (8R)-hydroperoxyeicosa-5,9,11, 14-tetraenoic acid (8-HPETE) during incubations with homogenates of the central nervous system of the marine mollusc, Aplysia californica. 8-HPETE can be reduced to the corresponding hydroxy acid or be enzymatically converted to a newly identified metabolite, 8-ketoeicosa-5,9,11,14-tetraenoic acid (8-KETE). These metabolites were identified by high performance liquid chromatography, UV absorbance, and gas chromatography/mass spectrometry. Stereochemical analysis of the products demonstrate that the neuronal enzyme is an (8R)-lipoxygenase. Previously we have shown that the neurotransmitters, histamine and Phe-Met-Arg-Phe-amide, activate 12-lipoxygenase metabolism in isolated identified Aplysia neurons. We now show that acetylcholine activates the (8R)-lipoxygenase pathway within intact nerve cells. Thus, both (12S)- and (8R)-lipoxygenase co-exist in intact Aplysia nervous tissue but are differentially activated by several neurotransmitters. The precise physiological role of the 8-lipoxygenase products is currently under investigation, but by analogy to the well-described 12-lipoxygenase pathway, we suggest that (8R)-HPETE and 8-KETE may serve as second messengers in Aplysia cholinoceptive neurons.

Acetylcholine↗